V-ATPase D Inhibitors belong to a class of chemical compounds designed to selectively target and modulate the activity of the V-ATPase D subunit. The V-ATPase (Vacuolar-type ATPase) is a multi-subunit enzyme complex found in various cellular membranes, including those of endosomes, lysosomes, and the plasma membrane. It plays a pivotal role in regulating intracellular pH, ion homeostasis, and the acidification of cellular compartments. The V-ATPase D subunit is one of the essential components of this complex, contributing to its function in proton translocation across membranes.
Inhibitors of the V-ATPase D subunit are designed to interfere with the proton-pumping activity of the V-ATPase complex. These inhibitors typically target the catalytic subunits of the enzyme, including the V-ATPase D subunit, to block its role in proton transport. By inhibiting the activity of the V-ATPase D subunit, these compounds can disrupt pH regulation within intracellular compartments, leading to alterations in vesicular trafficking, protein processing, and other cellular processes that rely on proper pH maintenance. Researchers study V-ATPase D inhibitors to investigate the functional consequences of V-ATPase inhibition on cellular physiology and to gain insights into the roles of V-ATPase complexes in various cellular processes, including endocytosis, autophagy, and lysosomal function. Understanding the effects of V-ATPase D inhibition contributes to a broader understanding of the intricate mechanisms that govern cellular homeostasis and compartmentalization.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | ¥1083.00 ¥2821.00 ¥8462.00 ¥16111.00 | 280 | |
巴夫洛霉素A1(Bafilomycin A1)通过不可逆地与V0结构域结合来抑制V-ATP酶,从而阻断质子易位途径。这种结合阻止了V0亚基的旋转,而V0亚基的旋转对于质子转运至关重要,最终导致溶酶体酸化的抑制。 | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | ¥733.00 ¥1828.00 ¥7333.00 ¥28769.00 | 109 | |
与巴佛洛霉素 A1 类似,康那霉素 A 也会与 V-ATP 酶的 V0 结构域结合,抑制质子在溶酶体膜上的转运。通过干扰 V0 亚基的旋转,康卡西霉素 A 能有效阻断 V-ATP 酶的质子泵活性,从而导致溶酶体酸化受损。 | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | ¥745.00 | 4 | |
奥美拉唑与 V-ATP 酶催化亚基内的半胱氨酸残基共价结合,从而抑制 V-ATP 酶,阻断胃酸分泌所必需的质子泵活性。 | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | ¥767.00 | 2 | |
氯喹通过在酸性囊泡内积累来抑制V-ATP酶,从而提高囊泡内pH值并破坏质子跨囊泡膜易位,最终损害溶酶体的酸化。 | ||||||
Dihydro Artemisinin | 71939-50-9 | sc-211332 | 100 mg | ¥2572.00 | 1 | |
二氢青蒿素通过干扰质子泵活性来抑制V-ATP酶,可能通过影响质子跨溶酶体膜易位所需的构象变化来抑制溶酶体酸化。 | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | ¥1579.00 ¥5641.00 | 2 | |
U18666A通过干扰质子跨溶酶体膜的转运来抑制V-ATP酶,可能通过影响酶的结构完整性或功能,最终导致溶酶体酸化受损。 |